Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-20 Sale | 2024-08-22 6:01 pm | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 4,181 | $1.2291 | $5,139 | 126,736 (Indirect Direct) | View |
| 2024-03-19 Sale | 2024-03-21 4:36 pm | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 6,562 | $2.0855 | $13,685 | 117,740 (Indirect Direct) | View |
| 2023-12-20 Sale | 2023-12-22 4:12 pm | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 4,077 | $1.3805 | $5,628 | 94,302 (Indirect Direct) | View |
| 2023-09-22 Sale | 2023-09-22 7:15 pm | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 4,119 | $1.3003 | $5,356 | 84,059 (Indirect Direct) | View |
| 2023-03-16 Sale | 2023-03-20 6:43 pm | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Financial Officer | 1,477 | $1.9792 | $2,923 | 76,928 (Indirect Direct) | View |
| 2022-07-20 Sale | 2022-07-21 4:11 pm | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 4,206 | $1.4222 | $5,982 | 38,405 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-20 Exercise | 2024-08-22 6:01 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 11,250 | $0 | 126,736 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 8:40 pm | N/A 2034-01-17 | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 245,000 | $0 | 339,302 (Direct) | View |
| 2023-12-17 Exercise | 2023-12-19 7:56 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 11,250 | $0 | 109,629 (Direct) | View |
| 2023-09-20 Option Award | 2023-09-22 7:15 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 11,250 | $0 | 84,059 (Direct) | View |
| 2023-02-02 Option Award | 2023-02-06 4:49 pm | N/A 2033-02-01 | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 215,000 | $0 | 253,405 (Direct) | View |
| 2022-08-10 Option Award | 2022-08-12 5:00 pm | N/A 2032-08-09 | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 157,500 | $0 | 157,500 (Direct) | View |
| 2022-07-19 Option Award | 2022-07-21 4:11 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 11,250 | $0 | 38,405 (Direct) | View |
Ownership | 2022-03-28 4:12 pm | N/A N/A | CytomX Therapeutics Inc. | CTMX | Landau Jeffrey B Chief Business Officer | 0 | $0 | 451,465 (Indirect) | View |